36 'Safer' Dividend Healthcare WallStars For September

Actionable Conclusions (1-10): Brokers Estimated Top Ten High Yield Healthcare "Safer" Dividend Stocks to Net 11.1% to 21.82% Gains To September 2019 Five of ten top 'safer' dividend Healthcare stocks by yield (shaded in the chart above) were verified as being among the top ten gainers for the coming year. Thus, based on analyst 1-year target prices, the dog strategy for this Health group graded out as 50% accurate.
Projections based on estimated dividends from $1000 invested in the ten highest yielding Healthcare stocks and aggregate one-year analyst mean target prices for those stocks, as reported by YCharts, created the 2019 data points. Note: one-year target prices from one analyst were not applied (n/a). Ten probable profit-generating trades to 2019 were:
Gilead Sciences (GILD) netted $218.17 based on estimates from twenty-eight analysts, plus dividends less broker fees. The Beta number showed this estimate subject to volatility 2% more than the market as a whole.
Sanofi (SNY) netted $215.01 based on a median of estimates from four analysts, plus dividends less broker fees. The Beta number showed this estimate subject to volatility 14% less than the market as a whole.
Grifols (GRFS) netted $189.05 based on estimates from five analysts, plus dividends less broker fees. The Beta number showed this estimate subject to volatility 18% more than the market as a whole.
AbbVie (ABBV) netted $178.47 based on a median target price estimate from... Read more